| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.33 | 4e-14 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.27 | 5e-13 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-11 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-08 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-08 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-07 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-06 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-06 |